Get started

Muy Ilustre Colegio Oficial de Farmacéuticos de Valencia

Homepage: micof.es
Alternate names: Colegio de Farmacéuticos de Valencia, Ilustre Colegio Oficial de Farmacéuticos de Valencia, Pharmaceutical Association of Valencia
ROR: 00fspzn07
OpenAlex ID: I4405266952
CRIDECO Anticholinergic Load Scale: An Updated Anticholinergic Burden Scale. Comparison with the ACB Scale in Spanish Individuals with Subjective Memory Complaints
2022 · Hernán Ramos, Lucrecia Moreno, et al. · Journal of Personalized Medicine · 87
PDF
Persistence as a Robust Indicator of Medication Adherence-Related Quality and Performance
2021 · Enrica Menditto, Caitriona Cahir, et al. · International Journal of Environmental Research and Public Health · 54
Bridging the Generational Digital Divide in the Healthcare Environment
2022 · Teresa Lopez de Coca, Lucrecia Moreno, et al. · Journal of Personalized Medicine · 41
PDF
The Need to Develop Standard Measures of Patient Adherence for Big Data: Viewpoint
2020 · Przemyslaw Kardas, Isabel Aguilar-Palacio, et al. · Journal of Medical Internet Research · 36
The A-to-Z factors associated with cognitive impairment. Results of the DeCo study
2023 · María Gil-Peinado, Mónica Alacreu, et al. · Frontiers in Psychology · 30
PDF
Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate
2021 · Hernán Ramos, Juan Pardo, et al. · Frontiers in Pharmacology · 30
PDF
The effect of an anti-inflammatory diet on chronic pain: a pilot study
2023 · Marta Sala-Climent, Teresa López de Coca, et al. · Frontiers in Nutrition · 27
Strengthening patients’ triage in community pharmacies: A cluster randomised controlled trial to evaluate the clinical impact of a minor ailment service
2022 · Noelia Amador-Fernández, Shalom I. Benrimoj, et al. · PLoS ONE · 21
PDF
Lifestyle Variables Such as Daily Internet Use, as Promising Protective Factors against Cognitive Impairment in Patients with Subjective Memory Complaints. Preliminary Results
2021 · Hernán Ramos, Mónica Alacreu, et al. · Journal of Personalized Medicine · 19
PDF
Pharmacists’ Knowledge of Factors Associated with Dementia: The A-to-Z Dementia Knowledge List
2021 · Hernán Ramos, Lucrecia Moreno, et al. · International Journal of Environmental Research and Public Health · 18
PDF
Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer’s disease: A population-based study
2024 · Mar Garcia Zamora, Gemma García–Lluch, et al. · Pharmacological Research · 16
Addressing Psychosocial Factors in Cognitive Impairment Screening from a Holistic Perspective: The DeCo-Booklet Methodology Design and Pilot Study
2022 · Cristina García, Lucrecia Moreno, et al. · International Journal of Environmental Research and Public Health · 12
PDF
Influence of statin potency and liposolubility on Alzheimer’s disease patients: A population-based study
2024 · Mar García-Zamora, Gemma García–Lluch, et al. · Pharmacological Research · 10
Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study
2023 · Gemma García-Lluch, Carmen Peña-Bautista, et al. · Pharmaceutics · 10
PDF
Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease
2024 · Gemma García-Lluch, Anna Marseglia, et al. · Journal of Alzheimer s Disease · 8
Impact of pharmacist-led interventions in identifying and resolving drug related problems and potentially inappropriate prescriptions among rural patients: A pilot study
2024 · Salvador Gutiérrez-Igual, Rut Lucas-Domínguez, et al. · Exploratory Research in Clinical and Social Pharmacy · 8
Colaboración farmacéutico-médico en la elaboración de protocolos consensuados para el tratamiento de síntomas menores: programa ‘INDICA+PRO’
2019 · Noelia Amador-Fernández, Shalom I. Benrimoj, et al. · Farmacéuticos Comunitarios · 7
PDF
Cardiovascular Risk Scales Association with Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cardiovascular Low Cardiovascular Risk Regions
2024 · G. García-Lluch, Juan Pardo Albiach, et al. · The Journal of Prevention of Alzheimer s Disease · 6
Unravelling facilitation complexity in community pharmacy: A pragmatic tool for implementation strategy selection
2025 · Emma L. Graham, Noelia Amador-Fernández, et al. · Research in Social and Administrative Pharmacy · 5
Nuevas herramientas para la revisión de la medicación: PRM en pacientes en tratamiento con inhibidores de la bomba de protones
2023 · Salvador Gutiérrez-Igual, Rut Lucas-Domínguez, et al. · Atención Primaria · 5
Identification of high-risk patients for referral through machine learning assisting the decision making to manage minor ailments in community pharmacies
2023 · Noelia Amador-Fernández, Shalom I. Benrimoj, et al. · Frontiers in Pharmacology · 5
PDF
Exploring associations between nutritional intake and cognitive performance in Spanish older adults
2025 · Teresa Lopez de Coca, Lourdes Bosch, et al. · Frontiers in Nutrition · 4
PDF
Influence of daily life and health profile in subtle cognitive decline of women residing in Spanish religious communities: DeCo religious orders study
2024 · Teresa Lopez de Coca, Lucrecia Moreno, et al. · Frontiers in Public Health · 4
Relationship Between Dietary Inflammatory Index, Diets, and Cardiovascular Medication
2025 · Teresa Lopez de Coca, Pablo Maya, et al. · Nutrients · 3
PDF
Selecting a Brief Cognitive Screening Test Based on Patient Profile: It Is Never Too Early to Start
2024 · Gemma García-Lluch, Ariadna Muedra-Moreno, et al. · Journal of Clinical Medicine · 3
PDF
Works count: 53
Citation count: 2,093
Year
Topic
Type